PD Dr. Agnes Bosch

Medizinische Fakultät Department of Medicine 4 – Nephrology and Hypertension

Is GFR decline induced by SGLT2 inhibitor of clinical importance? (2024) Günes-Altan M, Bosch A, Striepe K, Bramlage P, Schiffer M, Schmieder R, Kannenkeril D Journal article Relation between waist circumference and the renal hemodynamic in healthy individuals (2024) Bosch A, Kannenkeril D, Ott C, Striepe K, Schiffer M, Schmieder R Journal article Renal adaptation in pre-obesity patients with hypertension (2024) Bosch A, Rauh M, Striepe K, Schiffer M, Schmieder R, Kannenkeril D Journal article Blood pressure reduction after renal denervation in patients with or without chronic kidney disease (2024) Günes-Altan M, Schmid A, Ott C, Bosch A, Pietschner R, Schiffer M, Uder M, et al. Journal article Determinants of arterial stiffness in patients with type 2 diabetes mellitus: a cross sectional analysis (2023) Staef M, Ott C, Kannenkeril D, Striepe K, Schiffer M, Schmieder R, Bosch A Journal article Skin sodium content as a predictor of blood pressure response to renal denervation (2023) Günes-Altan M, Schmid A, Kannenkeril D, Linz P, Ott C, Bosch A, Schiffer M, et al. Journal article BLOOD PRESSURE REDUCTION AFTER RENAL DENERVATION IN PATIENTS WITH OR WITHOUT CHRONIC KIDNEY DISEASE: THE ERLANGER EXPERIENCE (2023) Schmid A, Ott C, Bosch A, Schiffer M, Uder M, Schmieder R, Kannenkeril D Conference contribution Angiotensin pathways under therapy with empagliflozin in patients with chronic heart failure (2023) Bosch A, Poglitsch M, Kannenkeril D, Kolwelter J, Striepe K, Ott C, Rauh M, et al. Journal article Is vascular remodelling in patients with chronic heart failure exaggerated? (2022) Pietschner R, Bosch A, Kannenkeril D, Striepe K, Schiffer M, Achenbach S, Schmieder R, Kolwelter J Journal article PCSK-9-inhibitor therapy improves endothelial function in high-risk patients with cardiovascular disease (2022) Kannenkeril D, Bosch A, Kolwelter J, Striepe K, Pietschner R, Ott C, Schiffer M, et al. Conference contribution